tiprankstipranks
Trending News
More News >

EVE Health Group Completes Share Purchase Plan

Story Highlights
EVE Health Group Completes Share Purchase Plan

Don’t Miss TipRanks’ Half-Year Sale

An update from EVE Health Group Limited ( (AU:EVE) ) is now available.

EVE Health Group has successfully completed its Share Purchase Plan (SPP), allowing eligible shareholders to purchase new fully paid ordinary shares at $0.036 per share, the same price as a recent placement. The company received applications totaling $32,500, resulting in the issuance of 902,766 new shares, which will rank equally with existing shares, potentially strengthening its financial position and shareholder base.

More about EVE Health Group Limited

EVE Health Group (ASX: EVE) is an Australian-based health company that focuses on developing and commercializing evidence-based wellness and pharmaceutical products. Through its subsidiaries, Meluka Australia and Nextract, EVE delivers science-led innovations to support consumer and practitioner health across retail, pharmacy, and clinical channels.

Average Trading Volume: 983,378

Technical Sentiment Signal: Sell

Current Market Cap: A$8.59M

For detailed information about EVE stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1